Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chemotherapy(Paclitaxel)-Induced Polyneuropathy in Breast Cancer as Part of the REBECCA Project (REsearch on BrEast Cancer Induced Chronic Conditions Supported by Causal Analysis of Multi-source Data)

NCT06052345 is registered in ClinicalTrials.gov with Theodoros Foukakis as lead sponsor.

NCT NCT06052345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06052345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chemotherapy(Paclitaxel)-Induced Polyneuropathy in Breast Cancer as Part of the REBECCA Project (REsearch on BrEast Cancer Induced Chronic Conditions Supported by Causal Analysis of Multi-source Data)
Lead sponsor
Theodoros Foukakis
Phase
Observational
Overall status
Withdrawn
Start date
March 31, 2024
Completion date
December 31, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast neoplasms, chemotherapy-induced peripheral neuropathy, early-stage breast cancer, non-metastatic breast carcinoma, polyneuropathy due to drugs, polyneuropathy; drug, quality of life